A detailed history of Ifp Advisors, Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 1 shares of CDXS stock, worth $4. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$4
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$2.91 - $5.81 $2 - $5
1 New
1 $0
Q3 2021

Oct 06, 2021

SELL
$19.65 - $27.99 $982 - $1,399
-50 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$18.08 - $28.8 $903 - $1,440
50 New
50 $1,000
Q4 2020

Jan 25, 2021

BUY
$11.7 - $23.41 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$11.21 - $13.82 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$9.8 - $12.77 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

SELL
$8.78 - $18.6 $13,319 - $28,216
-1,517 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$12.75 - $19.01 $19,341 - $28,838
1,517 New
1,517 $21,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $288M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.